# GSK vs HCA Healthcare: valuation, size and margins compared

URL: https://funkfolio.com/compare/gsk-vs-hca

> GSK ($98.7B, P/E 17.2) and HCA Healthcare ($104.7B, P/E 16.6) compared: size, valuation, margins, debt, cash and price change.

---

## GSK vs HCA Healthcare

GSK (GSK), health care, and HCA Healthcare (HCA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

HCA Healthcare is worth $104.7B on the stock market and GSK $98.7B: HCA Healthcare is valued at 6% more. GSK trades at 17.2 times earnings and HCA Healthcare at 16.6. Over the past year GSK's share price has moved +6.42% and HCA Healthcare's +7.04%.

### Key facts

- **GSK market value:** $98.7B
- **HCA Healthcare market value:** $104.7B
- **GSK P/E:** 17.2
- **HCA Healthcare P/E:** 16.6
- **GSK revenue:** $43.4B FY to 2025-12-31
- **HCA Healthcare revenue:** $75.6B FY to 2025-12-31
- **Superinvestors holding both:** 2

Market values as of 18 Nov 2026, 06:20 UTC.

GSK vs HCA Healthcare: every measure side by side

| Measure | GSK | HCA Healthcare |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United Kingdom | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $98.7B lower | $104.7B higher |
| Revenue | $43.4B lower | $75.6B higher |
| Earnings | $7.6B higher | $6.8B lower |
| Employees | 66,841 lower | 230,000 higher |
| Total assets | $81.1B higher | $60.7B lower |
| Valuation |  |  |
| P/E | 17.2 higher | 16.6 lower |
| P/S | 2.3 higher | 1.4 lower |
| P/B | — | — |
| Dividend yield | — | 0.60% |
| Profitability |  |  |
| Operating margin | 24.3% | — |
| Balance sheet |  |  |
| Net assets | $21.7B higher | -$6B lower |
| Total liabilities | $59.9B lower | $63.5B higher |
| Total debt | $19.2B lower | $46.5B higher |
| Cash on hand | $4.5B higher | $1B lower |
| Price change |  |  |
| Today | -2.32% lower | -2.07% higher |
| 1 year | +6.42% lower | +7.04% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: GSK 103.6, HCA Healthcare 105.0.

- GSK (GSK)
- HCA Healthcare (HCA)

GSK and HCA Healthcare share prices over one year, rebased to 100: GSK ends at 103.6, HCA Healthcare at 105.0.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | GSK | HCA |
| --- | --- | --- |
| Nov 28, 2025 | 100.7 | 106.5 |
| Dec 31, 2025 | 103.2 | 97.9 |
| Jan 30, 2026 | 108.6 | 102.3 |
| Feb 27, 2026 | 124.4 | 111.0 |
| Mar 31, 2026 | 116.1 | 99.2 |
| Apr 30, 2026 | 110.1 | 91.1 |
| May 29, 2026 | 106.3 | 79.3 |
| Jun 30, 2026 | 110.3 | 81.7 |
| Jul 31, 2026 | 108.8 | 84.4 |
| Aug 31, 2026 | 105.7 | 86.9 |
| Sep 30, 2026 | 101.3 | 89.4 |
| Oct 30, 2026 | 104.2 | 99.2 |
| Nov 17, 2026 | 103.6 | 105.0 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (2)

- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.5% / 0.9%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) &lt;0.1% / 0.1%

#### GSK only (9)

- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.1%
- [Thomas Kahn](https://funkfolio.com/gurus/thomas-kahn) 0.9%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.8%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.5%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 0.4%
- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 0.3%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 0.1%
- [Murray Stahl](https://funkfolio.com/gurus/murray-stahl) &lt;0.1%

#### HCA Healthcare only (15)

- [Colin Moran](https://funkfolio.com/gurus/colin-moran) 56.5%
- [Andrew Wellington](https://funkfolio.com/gurus/andrew-wellington) 3.8%
- [Lew Sanders](https://funkfolio.com/gurus/lew-sanders) 3.6%
- [Matthew McLennan](https://funkfolio.com/gurus/first-eagle) 2.2%
- [Anand Desai](https://funkfolio.com/gurus/anand-desai) 1.9%
- [Anthony Bozza](https://funkfolio.com/gurus/anthony-bozza) 0.7%
- [Steven Romick](https://funkfolio.com/gurus/steven-romick) 0.7%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.6%
- [Doug Silverman](https://funkfolio.com/gurus/doug-silverman) 0.6%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.3%
- [Tom Gayner](https://funkfolio.com/gurus/tom-gayner) 0.3%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) 0.1%
- [Diamond Hill team](https://funkfolio.com/gurus/diamond-hill) 0.1%
- [Glenn Greenberg](https://funkfolio.com/gurus/glenn-greenberg) &lt;0.1%
- [Temasek](https://funkfolio.com/gurus/temasek) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": GSK / HCA Healthcare). [Who owns GSK](https://funkfolio.com/stock/GSK/superinvestors) · [Who owns HCA](https://funkfolio.com/stock/HCA/superinvestors)

### More on GSK

- [GSK (GSK) stock page](https://funkfolio.com/stock/GSK)
- [GSK market cap](https://funkfolio.com/stock/GSK/market-cap)
- [GSK revenue](https://funkfolio.com/stock/GSK/revenue)
- [GSK P/E ratio](https://funkfolio.com/stock/GSK/pe-ratio)
- [GSK operating margin](https://funkfolio.com/stock/GSK/operating-margin)
- [GSK total debt](https://funkfolio.com/stock/GSK/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on HCA Healthcare

- [HCA Healthcare (HCA) stock page](https://funkfolio.com/stock/HCA)
- [HCA Healthcare market cap](https://funkfolio.com/stock/HCA/market-cap)
- [HCA Healthcare revenue](https://funkfolio.com/stock/HCA/revenue)
- [HCA Healthcare P/E ratio](https://funkfolio.com/stock/HCA/pe-ratio)
- [HCA Healthcare operating margin](https://funkfolio.com/stock/HCA/operating-margin)
- [HCA Healthcare total debt](https://funkfolio.com/stock/HCA/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### GSK against its closest peers

- [GSK vs CVS Health](https://funkfolio.com/compare/cvs-vs-gsk)
- [GSK vs Moderna](https://funkfolio.com/compare/gsk-vs-mrna)
- [GSK vs Regeneron Pharmaceuticals](https://funkfolio.com/compare/gsk-vs-regn)

#### HCA Healthcare against its closest peers

- [HCA Healthcare vs CVS Health](https://funkfolio.com/compare/cvs-vs-hca)
- [HCA Healthcare vs Moderna](https://funkfolio.com/compare/hca-vs-mrna)
- [HCA Healthcare vs Sanofi](https://funkfolio.com/compare/hca-vs-sny)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, GSK or HCA Healthcare?**

By market value, HCA Healthcare is the larger: $104.7B against $98.7B for GSK. By revenue in its latest fiscal year, HCA Healthcare is the larger: $75.6B against $43.4B for GSK.

**Which has the higher P/E ratio?**

GSK: 17.2, against 16.6 for HCA Healthcare. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has more debt?**

HCA Healthcare: $46.5B, against $19.2B for GSK. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both GSK and HCA Healthcare?**

In their latest 13F filings, Charles Brandes (founder) and Richard Pzena hold both.

### Cite this page

Funkfolio, “GSK vs HCA Healthcare”, data as of 18 November 2026. https://funkfolio.com/compare/gsk-vs-hca

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
